Abigail M Rubio

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Impact ofompk36genotype and KPC subtype on thein vitroactivity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producingK. pneumoniaeclinical isolates”.

Impact ofompk36genotype and KPC subtype on thein vitroactivity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producingK. pneumoniaeclinical isolates

JAC-Antimicrobial Resistance(2023)10.1093/jacamr/dlad022

N/A

0DataRank · unranked

16 citations

Ellen G Kline, M. Patrick Griffith, Chelsea E Jones, Abigail M Rubio, Kevin M Squires +2 more

Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae

JAC-Antimicrobial Resistance(2023)10.1093/jacamr/dlad113

N/A

0DataRank · unranked

10 citations

Ellen G Kline, M. Patrick Griffith, Chelsea E Jones, Abigail M Rubio, Kevin M Squires +2 more